P
US8778665B2ActiveUtilityPatentIndex 97

Detection and quantification of analytes in bodily fluids

Assignee: GIBBONS IANPriority: Nov 14, 2006Filed: Mar 30, 2010Granted: Jul 15, 2014
Est. expiryNov 14, 2026(~0.4 yrs left)· nominal 20-yr term from priority
Inventors:GIBBONS IANROY SHAUNAKKU EDMOND
Y10T436/20G01N 21/31B01L 2300/0887B01L 2300/0654G01N 33/5302G01N 21/27C12Q 1/60B01L 2300/0874B01L 2200/0631G01N 2201/061B01L 3/502707B01L 3/502715B01L 2200/10G01N 33/525G01N 2201/062G01N 33/92B01L 2300/087B01L 3/502753B01L 2300/0819B01L 2300/168B01L 2200/0605
97
PatentIndex Score
75
Cited by
329
References
27
Claims

Abstract

This invention is in the field of medical devices. Specifically, the present invention provides portable medical devices that allow detection of analytes from a biological fluid. The methods and devices are particularly useful for providing point-of-care testing for a variety of medical applications.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
       1. A system for detecting at least one analyte in a bodily fluid from a subject, the system comprising:
 a light source comprising a coating of luminescent paint and having an emission spectrum; 
 an assay assembly having one or more reactants to react with the bodily fluid to yield a colored product having an absorbance spectrum encompassing at least one wavelength within the emission spectrum from the light source; and 
 a detector that detects absorption of the at least one wavelength of light directed through the colored product, wherein said absorption of said at least one wavelength through the colored product is indicative of the presence of the analyte in said bodily fluid. 
 
     
     
       2. The system of  claim 1  wherein the detector is configured to detect at least two different analytes in the bodily fluid. 
     
     
       3. The system of  claim 1  wherein the amount of absorption is stoichiometrically related to the concentration of the analyte in said bodily fluid. 
     
     
       4. The system of  claim 1  wherein the assay assembly is configured to run an immunoassay or an enzymatic assay yielding the colored product. 
     
     
       5. The system of  claim 1  wherein the light source comprises a light emitting diode. 
     
     
       6. The system of  claim 1  wherein the wavelength is in a range of about 400 to about 800 nm. 
     
     
       7. The system of  claim 1  wherein the light source comprises a monochromatic light source having a wavelength that is encompassed by the absorbance spectrum. 
     
     
       8. The system of  claim 1  wherein the light source comprises a filter having a wavelength that is encompassed by the absorbance spectrum. 
     
     
       9. The system of  claim 1  wherein the analyte is specifically bound by an antibody that is detected by a secondary enzyme-linked antibody that catalyzes a color-producing reaction. 
     
     
       10. The system of  claim 1  wherein the analyte is converted chemically to the colored product via a color-producing reaction. 
     
     
       11. The system of  claim 1  wherein the analyte catalyzes the formation of the colored product from said reactants. 
     
     
       12. The system of  claim 1  further comprising a chemical reagent that bind the analyte binds with an agent that participates in a color-producing reaction. 
     
     
       13. The system of  claim 3  wherein the amount of absorption is linearly related to the concentration of the analyte in said bodily fluid. 
     
     
       14. The system of  claim 1  wherein the volume of bodily fluid is less than about 50 μl. 
     
     
       15. A fluidic device for detecting the presence or absence of at least one analyte in a bodily fluid from a subject, the device comprising:
 a cartridge comprising a sample collection unit, an assay assembly, and a light source; 
 wherein said light source comprises luminescent paint coated in said assay assembly, and 
 wherein said sample collection unit is configured to collect a sample of bodily fluid from said subject and wherein said assay assembly comprises at least one reaction site containing a reactant that reacts with said analyte to yield a colored product having an absorbance spectrum corresponding to at least one wavelength of light directed through the colored product by said light source. 
 
     
     
       16. The fluidic device of  claim 15 , wherein said sample collection unit comprises a sample collection well, a metering channel, and a dilution chamber in fluidic communication with said metering channel, wherein said dilution chamber is configured to store a diluent. 
     
     
       17. The fluidic device of  claim 16 , wherein said sample collection unit further comprises a mixing chamber that is configured to mix a predetermined portion of the sample with the diluent to yield a diluted sample. 
     
     
       18. The fluidic device of  claim 17 , wherein the sample collection unit further comprises a filter configured to filter the diluted sample before it is assayed. 
     
     
       19. The fluidic device of  claim 15 , wherein the absorbance spectrum of the colored product overlaps by at least 70% with an emission spectrum from the light source. 
     
     
       20. The system of  claim 1  wherein the detector is configured to detect the absorption of the at least one wavelength of light at a reaction site where the reactants react with the bodily fluid within the assay assembly. 
     
     
       21. The system of  claim 1  wherein the detector is configured to detect the absorption of the at least one wavelength of light at a detection site after the colored product has been transported from a reaction site where the reactants react with the bodily fluid within the assay assembly. 
     
     
       22. The system of  claim 1  wherein the assay assembly comprises at least one well in which the reactants react with the bodily fluid. 
     
     
       23. The system of  claim 22  wherein the well is cylindrical in shape and includes a defined length between two opposed flat surfaces, wherein at least one of the flat surfaces is transparent. 
     
     
       24. The system of  claim 23  wherein the light source and the detector are on the same side of the well where the one or more reactants react with the bodily fluid. 
     
     
       25. The system of  claim 23  wherein the light source and the detector are on opposite sides of the well where the one or more reactants react with the bodily fluid. 
     
     
       26. The system of  claim 1  wherein the assay assembly comprises multiple reaction sites where one or more reactants react with the bodily fluid, the multiple reaction sites comprising different reactants to detect different analytes in the bodily fluid. 
     
     
       27. The system of  claim 26  wherein the multiple reaction sites and the detector are movable relative to one another.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.